COMPANY
Cipla USA, Inc.
Cipla USA, Inc.: US labeler, recalling firm for Calcitonin, Glucagon, Icatibant, Lanreotide, Leuprolide, Liraglutide, as stated by public registers.
Also written as: Cipla USA Inc.; CIPLA USA INC..
US LABELER
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| Calcitonin | CALCITONIN SALMON, ANDA Regulator openFDA |
|---|---|
| Glucagon | Glucagon, ANDA Regulator openFDA |
| Icatibant | ICATIBANT, ANDA Regulator openFDA |
| Lanreotide | LANREOTIDE ACETATE, ANDA Regulator openFDA |
| Lanreotide | Lanreotide Acetate, NDA Regulator openFDA |
| Leuprolide | LEUPROLIDE ACETATE DEPOT, NDA Regulator openFDA |
| Liraglutide | liraglutide, ANDA Regulator openFDA |
| Liraglutide | LIRAGLUTIDE, ANDA Regulator openFDA |
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Lanreotide | Class II recall, Ongoing, 2026-01-21 Regulator openFDA |
|---|---|
| Lanreotide | Class II recall, Ongoing, 2026-04-15 Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.